Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery
Apply
CBM588 & Pembrolizumab
Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step